Axonics Inc (AXNX) Reports Robust Revenue Growth and Margin Expansion in Q4 and FY 2023 [Yahoo! Finance]
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Gross Margin Improvement : Gross margin expanded to 74.9% for the fiscal year, up from 72.2% in the prior year, reflecting improved operational efficiency. Net Income Surge in Q4 : Fourth quarter net income rose to $6.6 million, a substantial increase from $0.7 million in the same period last year. Adjusted EBITDA Growth : Adjusted EBITDA for the fiscal year soared to $52.3 million, a significant improvement from $1.6 million in the prior year. Liquidity Position : The company reported a strong liquidity position with $358 million in cash, cash equivalents, short-term investments, and restricted cash as of December 31, 2023. On February 28, 2024, Axonics Inc ( NASDAQ:AXNX ) released its 8-K filing , detailing the financial results for the fourth quarter and fiscal year ended December 31, 2023. The company, a leading medical technology firm focused on developing and commercializing innovative products for bladder and bowel dysfunction, has reported a year of strong financial p
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Axonics Reports First Quarter 2024 Financial ResultsBusiness Wire
- Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash [Seeking Alpha]Seeking Alpha
- FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Reuters]Reuters
- FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]Yahoo! Finance
AXNX
Earnings
- 10/30/23 - Beat
AXNX
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/29/24 - Form 10-K/A
- AXNX's page on the SEC website